Paradigm bought Deep Lens, the AI spinoff that uses genomics and EHR data to find oncology patients for clinical trials, as part of its launch.
Venture capital firms General Catalyst and Arch Venture Partners co-led the financing round, which also featured the American Cancer Society’s BrightEdge fund. General Catalyst’s Stephen Klasko, MD, a former health system leader, was named to Paradigm’s board.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.